Researchers sought to assess the incidence of and risk factors for cardiotoxicity related to anthracycline therapy in a ...

High-dose chemotherapy (HDC) can have cardiotoxic effects. Experimental data have indi-cated that angiotensin-converting-enzyme inhibitors could prevent cardiotoxicity following HDC. Now ...

Chemotherapy may cause heart damage (cardiotoxicity), either early on or later in treatment. While some effects may be mild, such as changes in blood pressure, more severe reactions can lead to ...

The initial step in the management of new-onset ventricular dysfunction in patients with cancer exposed to potentially cardiotoxic chemotherapy is to exclude other causes of cardiac dysfunction ...

prospective exploration of molecular markers to identify populations of patients who will derive maximal benefit from anthracycline-based chemotherapy, and the identification of less cardiotoxic ...